DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas

BACKGROUND: The clinical signs of active trachoma are often present in the absence of ocular Chlamydia trachomatis infection, particularly following mass drug administration. Treatment decisions following impact surveys and in post-control surveillance for communities are currently based on the prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Derrick, Tamsyn R., Sandetskaya, Natalia, Pickering, Harry, Kölsch, Andreas, Ramadhani, Athumani, Mafuru, Elias, Massae, Patrick, Malisa, Aiweda, Mtuy, Tara, Burton, Matthew J., Holland, Martin J., Kuhlmeier, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590679/
https://www.ncbi.nlm.nih.gov/pubmed/33109267
http://dx.doi.org/10.1186/s13071-020-04414-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590679/
https://www.ncbi.nlm.nih.gov/pubmed/33109267
http://dx.doi.org/10.1186/s13071-020-04414-6

Ejemplares similares